B reast cancer is the leading site of new cancer patients in Thai females (41.96% of all female cancers) according to Thai cancer registry of 2015. 1 Mammogramphy is widely accepted for screening breast cancer. However, the low sensitivity of mammography for dense breasts, women younger than 50 years of age and small-sized cancers remains a major limitation. 2 The use of ultrasonography as adjunctive tool to mammography increases detection rate of screening mammography. 3 There is a shortage of both physicians and well-trained technologists to perform breast ultrasound screening. 4 Automated breast ultrasound (ABUS) is a novel approach for breast screening ultrasound in which the image acquisition is uncoupled from the interpretation. The study is reviewed by the radiologist on a dedicated workstation using the entire dataset for interpretation. Compared with technologist-performed bilateral handheld ultrasound, in which representative images are presented for interpretation, automated breast ultrasound allows the physician to interpret the entire study and identify the suspicious lesions. Furthermore, automated breast ultrasound allows improved consistency and reproducibility of images, minimizes operator dependence, and aids with inclusion of the entirety of the breast. It does not require physician time for image acquisition and allows review of the study at either the time of acquisition or a later time.ABUS is also cost-effective. 5 Therefore the U.S. Food and Drug Administration approved ABUS as the only approved system of its kind for screening women with dense breast tissue.Our department started installation of ABUS screening in a bus in order to perform adjunctive breast ultrasonography for mobile breast cancer screening. We present our initial experience and discuss its role in breast screening. Abstract BACKGROUND:To assess diagnostic value of automated breast volume scanning (ABVS) versus handheld ultrasonography (HHUS) in breast cancer screening. MATERIALS AND METHODS: All 110 participants received an ABVS examination compared with HHUS which was set up as a standard tool. The scans were interpreted by specialists blinded to the results of breast imaging and medical history. Cohen Kappa value was used to interpret agreement between diagnostic tools. RESULTS: On the basis of the Breast Imaging Reporting and Data System (BI-RADS) classification, of the 110 cases, an agreement was achieved in 102 cases (92.7%). Kappa value (K) was 0.885 representing almost perfect agreement. CONCLUSION: We concluded that ABVS is comparable to HHUS as an adjunctive tool to mammography for screening of breast cancer
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.